<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This is the first case report describing transcatheter arterial chemoembolization (TACE) with docetaxel-loaded microspheres which was successful in controlling <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We report on a 50-year-old woman with unresectable <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Since November 2007, the patient had received 12 courses of mFOLFOX6 (LV/5-FU/L-OHP) as the 1st line therapy, 18 courses of LV/5-FU as the 2nd line therapy, 16 courses of FOLFIRI (LV/5-FU/<z:chebi fb="9" ids="27656">CPT</z:chebi>-11) + bevacizumab as the 3rd line therapy, and 32 courses of cetuximab as the 4th line therapy </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> treatments had been conducted after confirmation of the disease progression </plain></SENT>
<SENT sid="4" pm="."><plain>The patient experienced hepatic dysfunction, upper <z:hpo ids='HP_0002027'>abdominal pain</z:hpo> and malaise due to the growth of metastatic <z:e sem="disease" ids="C0023903" disease_type="Neoplastic Process" abbrv="">liver tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Since December 2009, the patient received 3 courses of TACE with docetaxel-loaded microspheres in combination with hepatic arterial infusion of 20 mg <z:chebi fb="2" ids="27899">cisplatin</z:chebi> (CDDP) in a palliative setting for the treatment of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>, which resulted in a reduction or <z:mp ids='MP_0001651'>necrosis</z:mp> of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and improvement in hepatic function and symptoms </plain></SENT>
<SENT sid="6" pm="."><plain>TACE with docetaxel-loaded microspheres may be a palliative therapy for patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> who are refractory to the current standard systemic chemotherapy and have predominant <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
</text></document>